Are drugs designed to work best for all patients?
Are randomised controlled trials achieving the results we need for patients? In the latest instalment of ERS Vision, Professor Elisabeth Bel leads a discussion on the relevance of real-life evidence and whether it can enhance existing guidelines.
The documentary considers how we can ask the right questions to provide the right solutions for each individual patient. Leading experts consider the value of this type of research, along with the issues surrounding quality standards, costs and how it can be effectively designed and applied.
European Respiratory Society: Should we be testing new drugs in the ‘real’ world where some patients smoke, are obese and have other comorbidities?
Share this post
Latest News posts
Tribute to Steph Smith – October 2010
December 6, 2018
Avoiding Respiratory Infections
November 29, 2018
Marijuana use and aspergillosis
November 23, 2018
Gardening
November 22, 2018
Dehumidifiers
November 16, 2018
Anti-allergen products
November 16, 2018
Air conditioning units and Aspergillus
November 15, 2018
… remove mould from my home?
November 9, 2018
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video